Skip to content

Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy

Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04000828
Enrollment
12
Registered
2019-06-27
Start date
2019-05-22
Completion date
2020-04-14
Last updated
2021-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

A 24 hour profile is recorded using Sensimed Triggerfish in glaucoma patients before and after Trabecuelctomy

Interventions

DEVICEPlacement of Sensimed Triggerfish

Sensimed Triggerfish is placed on the corneal surface

Sponsors

Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient must have the willingness and ability to provide signed informed consent * Patient is able to comply with the study procedure * Patient must be ≥ 18 years old * Diagnosis of primary open angle glaucoma (EGS criteria) including pseudoexfoliation glaucoma/ normal tension glaucoma/ pigmentary glaucoma in the study eye * planned trabeculectomy in the study eye * in preparation for trabeculectomy, all preoperative IOP lowering medication has been replaced by Dorzolamid 20 mg/ml + Timolol 5mg/ml preservative free eye drops in the study eye for at least 28 days before Triggerfish® profile * Patient has consented to be in the trial and signed informed consent is available before any study related procedures are carried out * Visual Acuity of 20/200 or better in both eyes * Ability of subject to understand the character and individual consequences of the study

Exclusion criteria

* Subjects with contraindications for wearing contact lenses in the study eye * secondary glaucoma in the study eye * History of refractive surgery in the study eye * History of intraocular surgery in the last three months in the study eye * Severe dry eye syndrome as judged by the investigator in the study eye * Keratoconus or other corneal abnormalities * Any other abnormality in the study eye, that prevents the safe placement of the device after investigators decision * Conjunctival or intraocular inflammation in the study eye * Simultaneous participation in other clinical trials * Previous IOP-lowering intervention in the study eye * Current shift workers (applicable for at least 3 months) * Transmeridian flight \< 2 months before screening (6 hours time shift) * Subjects with pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Amplitudeup to 14 weeksComparison of Amplitude between the preoperative Triggerfish Profile and the Triggerfish Profile three months after Trabeculectomy

Secondary

MeasureTime frameDescription
Correlation of other parametersup to 14 weeksCorrelation of IOP and Triggerfish Profile, Correlation of IOP, blood pressure and heart rate, Evaluation of 24 hours nyctohemeral rhythm of measurements before and after trabeculectomy

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026